以上内容来自Benzinga Earnings专栏,原文如下:
ClearPoint Neuro (NASDAQ:CLPT) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.16) by 25 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $7.77 million which missed the analyst consensus estimate of $8.23 million by 5.57 percent. This is a 14.11 percent increase over sales of $6.81 million the same period last year.
精彩评论